COMMUNIQUÉ RÉGLEMENTÉ

par INTER PARFUMS (EPA:ITP)

2025 results. Solid performance in an unstable environment. Operating margin: 19.5% - Net margin: 14.1% - Dividend per share: €1.05

2025 results

Solid performance in an unstable environment

Operating margin: 19.5% - Net margin: 14.1% - Dividend per share: €1.05

Despite 2025 being marked by many external factors that negatively impacted its business, including a turbulent geopolitical and macroeconomic environment, a very unfavorable euro/dollar exchange rate and the introduction of tariffs in the United States, Interparfums posted strong results with still high margins.

Income statement1 - €m20232024202525/24
Sales798.5880.5899.4+2%
Gross margin
% of sales
525.0
65.8%
577.8
65.6%
582.1
64.7%
+1%
Operating income
% of sales
165.6
20.7%
178.0
20.2%
175.2
19.5%
-2%
Net income attributable to owners of the parent
% of sales
118.7
14.9%
129.9
14.8%
126.6
14.1%
-3%

Although the 2025 gross margin fell by nearly a point compared to fiscal year 2024, this was attributed entirely to the introduction of tariffs in the United States, given that hedging set up at the beginning of the year helped limit the currency effect on the gross margin.

In 2025, Interparfums continued to focus its investments on the steady development of its brands, with nearly €192 million – more than 21% of its sales – spent on marketing and advertising. Against this backdrop, 2025 operating income, which includes a total impact of €7.6 million in tariffs, was down only slightly thanks to overall cost control. Excluding tariffs, pro forma operating income rose nearly 3% to €182.8 million, bringing the restated operating margin to 20.3%, stable compared to 2024.

Just as net financial income/expense was mainly impacted by the cost of hedging and financial debt, net income followed the same trend. Excluding tariffs, pro forma net income was €132.3 million, 2% higher than in 2024, bringing the net margin to 14.7%, also stable compared to 2024.

Balance sheet1 - €m12/31/2312/31/2412/31/2525/24
Inventory202.4229.7197.2-14%
Cash and cash equivalents177.7190.6204.5+7%
Shareholders’ equity644.0699.0732.0+5%
Borrowings & financial liabilities123.0133.4141.2+6%

The return to shorter procurement times over the past several quarters led to a significant reduction in inventories, which were at more normative levels at December 31, 2025, thereby contributing to a positive change in operating cash flow. The Group’s financial position remains very strong, with €63 million in cash net of borrowings and financial liabilities and €732 million in shareholders’ equity, representing nearly 70% of the balance sheet at December 31, 2025.

Dividend and bonus share issue

On February 24, 2026, the company’s Board of Directors approved the 2025 financial statements and decided to propose to the Combined Shareholders’ Meeting of April 24, 2026 a dividend of €1.05 per share2, stable3 compared with last year, thanks to a payout ratio of nearly 70% of net income for the year. In keeping with a practice introduced in 1999, a new bonus share grant will also be proposed in June for the 27th straight year.

Board of Directors

On the recommendation of the Governance, Nominations and Compensation Committee, the company’s Board of Directors decided to propose to the Combined Shareholders’ Meeting of April 24, 2026:

  • the appointment of Natalie Bader Messian as independent director for a four-year period following her co-option in September 2025 to replace Véronique Morali;
  • renewal of the terms of Constance Benqué and Olivier Mauny for three more years, as part of the staggering of terms of office.

As was the case last year, following the Shareholders’ Meeting, the company’s Board of Directors will consist of eight directors, including four women and four men, five independent members and three non-independent members, thereby maintaining the two-fold objective in terms of gender equality and independence, first achieved in April 2022. On that date, the Audit Committee, the Governance, Nominations and Compensation Committee and the CSR Committee will also continue to be made up entirely of independent members, 67% of whom will be women.

Corporate social responsibility

In 2025, Interparfums have continued its efforts in environmental subjects, which resulted in an improvement in all its extra-financial ratings, including MSCI, Sustainalytics, EcoVadis and EthiFinance. The company’s decarbonization pathway was also validated by the SBTi (Science Based Targets initiative).

In addition, employee-related initiatives were bolstered with the introduction of the following benefits in 2025:

  • A fourth performance share plan for all employees worldwide;
  • Additional profit-sharing for all employees in France in line with previous years.
Q1 2026 outlook

Activity in the first quarter of 2026 will be impacted by a high basis of comparison resulting from:

  • The unfavorable trend in the euro/dollar exchange rate between Q1 2025 (1.05 on average) and Q1 2026 (expected to be around 1.18), with the percentage of sales in dollars exceeding 50% in 2025;
  • The intense launch program in late 2024 and early 2025;
  • A later launch program in 2026.

Paris, February 25, 2026

ISIN : FR0004024222-ITP
Reuters : IPAR.PA
Bloomberg : ITP
Euronext Compartment A
Eligible for Deferred
Settlement Service (SRD)
Eligible for PEA
Index - SBF 120, CAC Mid 60

This press release
is available in French
and English on the
company’s website
interparfums-finance.fr

Interparfums
10 rue de Solférino
75007 Paris
+33 (0)1 53 77 00 00

Investor Relations and Analysts Contact

Philippe Santi
Executive Vice President
psanti@interparfums.fr

Nicolas Picaud
Investor Relations Manager
npicaud@interparfums.fr

Press Contact

Cyril Levy-Pey
Communication Director
clevypey@interparfums.fr

Certidox

Consolidated financial statements

Consolidated income statement
(€ thousands)20242025
Sales880,493899,383
Cost of sales(302,706)(317,250)
Gross margin577,787582,133
% of sales65.6%64.7%
Selling expenses(364,621)(371,402)
Administrative expenses(34,886)(35,497)
Current operating income178,280175,234
% of sales20.2%19.5%
Other operating expenses(3,700)
Other operating income3,469
Operating profit178,049175,234
% of sales20.2%19.5%
Financial income6,9704,641
Gross cost of debt(6,757)(5,801)
Net cost of debt214(1,160)
Other financial income9,12321,022
Other financial expenses(13,133)(29,085)
Net financial income/(expense)(3,796)(9,223)
Income before tax174,253166,011
% of sales19.8%18.5%
Income tax(44,391)(39,816)
Tax rate25.5%24.0%
Share of profit from equity-accounted companies425831
Net income130,287127,027
% of sales14.8%14.1%
Share attributable to non‑controlling interests419457
Net income attributable to owners of the parent129,868126,569
% of sales14.7%14.1%
Net earnings per share in euros11.701.58
Diluted earnings per share in euros11.701.58
Consolidated balance sheet
ASSETS20242025
(€ thousands)
Non‑current assets
Trademarks and other intangible assets240,397251,377
Property, plant and equipment143,763154,268
Right-of-use assets13,22612,700
Long‑term investments2,6562,830
Non-current financial assets2,654897
Equity-accounted investments12,89313,213
Deferred tax assets20,96417,903
Total non‑current assets436,553453,187
Current assets
Inventory and work‑in‑progress229,722197,222
Trade receivables and related accounts164,198168,507
Other receivables11,51516,430
Corporate income tax2949,541
Current financial assets7,5613,285
Cash and cash equivalents183,077201,210
Total current assets596,367596,195
Total assets1,032,9191,049,382
SHAREHOLDERS’ EQUITY AND LIABILITIES20242025
(€ thousands)
Shareholders’ equity
Share capital228,349251,385
Additional paid‑in capital1,919
Reserves338,805350,110
Net income for the year129,868126,569
Total shareholders’ equity attributable to owners of the parent697,022729,984
Non‑controlling interests1,5361,700
Total shareholders’ equity698,558731,684
Non‑current liabilities
Provisions for non-current expenses4,7914,263
Non-current borrowings and financial liabilities95,91296,109
Non‑current lease liabilities10,8217,848
Deferred tax liabilities6,5077,313
Total non‑current liabilities118,031115,534
Current liabilities
Trade payables and related accounts105,24996,556
Current borrowings and financial liabilities37,51845,116
Current lease liabilities3,2193,215
Provisions for contingencies and expenses
Corporate income tax8,0341,549
Other liabilities62,31155,728
Total current liabilities216,331202,164
Total shareholders’ equity and liabilities1,032,9191,049,382
Consolidated statement of cash flows
(€ thousands)20242025
Cash flows from operating activities
Net income130,287127,027
Depreciation, provisions for impairment and other22,46030,632
Share of profit from equity-accounted companies(425)(831)
Net cost of debt2,9714,561
Tax expense for the period44,39139,816
Cash flows from operations before interest and tax199,683201,204
Interest paid and received(430)(1,184)
Tax paid(47,854)(53,997)
Cash flows from operations after interest and tax151,399146,023
Changes in inventories and work-in-progress(19,301)23,332
Change in trade receivables and related accounts(20,734)(12,523)
Change in other receivables(1,059)(10,254)
Change in trade payables and related accounts(10,094)(3,354)
Change in other liabilities7,4986,794
Change in working capital requirements(43,690)3,995
Net cash flows provided by (used in) operating activities107,709150,017
Cash flows from investing activities
Net acquisitions of intangible assets(16,173)(21,678)
Net acquisitions of property, plant and equipment(2,683)(18,540)
Net acquisitions of right-of-use assets(1,672)(324)
Acquisition of equity interests(1,988)
Net acquisitions of financial assets2,9981,048
Change in long‑term investments(633)(116)
Net cash flows provided by (used in) investing activities(18,162)(41,598)
Cash flows from financing activities
Issuance of borrowings and new financial debt40,00050,000
Loan repayments(29,635)(42,244)
(Issuance)/repayment of loan granted to stakeholders27,972
Net change in lease liabilities(1,424)(2,874)
Dividends paid(80,333)(87,620)
Own shares213(372)
Financial income/(expense)(2,004)(4,603)
Net cash flows provided by (used in) financing activities(45,211)(87,713)
Impact of conversion rates1,008(2,597)
Effect of changes in scope of consolidation23
Change in net cash45,34418,133
Opening cash and cash equivalents137,734183,077
Closing cash and cash equivalents183,077201,210
(€ thousands)20242025
Cash and cash equivalents183,077201,210
Current financial assets7,5613,285
Cash and current financial assets190,638204,495
Current borrowings and financial liabilities(37,518)(45,116)
Non-current borrowings and financial liabilities(95,912)(96,109)
Total gross debt(133,430)(141,225)
Net debt57,20863,270

The reconciliation of net debt breaks down as follows:

Notes

  1. Audit procedures carried out and audit report being prepared
  2. Ex-dividend date May 5, 2026 (12:00 a.m.) - Payment date May 7, 2026
  3. Given the June 2025 bonus share grant
  4. Restated on a prorated basis for bonus share issues.
Voir toutes les actualités de INTER PARFUMS